Skip to main content
. 2015 May 1;8(5):5062–5070.

Figure 2.

Figure 2

Exosomes derived from ovarian cancer have enhanced cell viability of HUVECs. (A) 10 µg/ml of exosomes purified from CAOV3 significantly enhanced cell viability of HUVECs after 48 h, but corresponding concentration of exosomes purified from SKOV3 prove of failed to significantly enhance cell viability of HUVECs in 72 h. (B) When the concentration of exosomes derived from CAOV3 and SKOV3 reached 50 µg/ml, cell viability of HUVECs all significantly enhanced after 48 h. (C) 10 µg/ml of exosomes purified from CAOV3 and 50 µg/ml of exosomes purified from SKOV3 enhanced HUVECs migration. The enhancement were more obviously in exosomes derived from CAOV3 than that from SKOV3. Quantification analysis data signified the means ± standard deviation (SD), n = 5; **P < 0.01, ***P < 0.001.